Author

Daniel Oberbauer

University of California, Davis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:long-read sequencing· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Abhineet R. RamiD· 1 shared Ilechukwu Agu· 1 shared Ivy R. José· 1 shared John G. AlbeckiD· 1 shared Samuel L. Díaz‐MuñoziD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abhineet R. RamORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Influenza A defective viral genomes and non-infectious particles are in-creased by host PI3K inhibition via anti-cancer drug alpelisib

Ilechukwu Agu, Ivy R. José, Abhineet R. Ram, Daniel Oberbauer, John G. Albeck, Samuel L. Díaz‐Muñoz

This study shows that alpelisib, a PI3K inhibitor, increases defective viral genomes and particles in A/H3N2 but decreases total particles in A/H1N1, suggesting host metabolism influences viral defectiveness.

Cell Communication and Signaling · Dec 19, 2025Peer-reviewedMicrobiology